Navigation Links
Life Technologies Announces Second Quarter 2013 Results
Date:7/31/2013

time costs including the early repayment of debt and the associated impacts, and the impact of certain settlements in order to provide a supplemental comparison of the results of operations.  LIFE TECHNOLOGIES CORPORATIONCONDENSED CONSOLIDATED BALANCE SHEETSJune 30,December 31,(in thousands)20132012ASSETS (unaudited) Current assets:Cash and short-term investments

$
290,379$
276,369Trade accounts receivable, net of allowance for doubtful accounts

675,725697,228Inventories

416,833403,488Prepaid expenses and other current assets

299,879248,154Total current assets

1,682,8161,625,239Long-term assets

6,800,9317,012,826Total assets

$
8,483,747$
8,638,065LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Current portion of long-term debt

$
4,208$
253,214Short-term borrowings

143,000100,000Accounts payable, accrued expenses and other current liabilities

787,035839,137Total current liabilities

934,2431,192,351Long-term debt

2,068,2242,060,855Other long-term liabilities

660,928731,396Stockholders' equity

4,820,3524,653,463Total liabilities and stockholders' equity

$
8,483,747$
8,638,065 LIFE TECHNOLOGIES CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWSFor the six monthsended June 30,(in thousands)(unaudited)20132012Net income$ 247,525$  254,942Add back amortization and share-based compensation

188,080197,206Add back depreciation

61,68162,005Balance sheet changes

(67,091)(46,413)Other noncash adjustments

(76,222)(107,773)Net cash provided by operating activities

353,973359,967Capital expenditures

(46,366)(49,075)Proceeds from sale of assets 

36,729328Free cash flow344,336311,220Net cash used in investing activities

(74,315)(61,101)Net cash used in financing activities

(259,346)(8
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. DryLet Technologies Announces the Rebranding and Launch of Patented ManureMagicâ„¢
2. Life Technologies Signs Five-Year Agreement with the FDA
3. Biomarkers - Technologies, Markets and Companies - Updated 2012 Report
4. Todays Research: Life Technologies, Opko Health, Medicines, and DaVita
5. Molecular Diagnostics: Technologies, Markets and Companies - 2013 Report
6. Life Technologies Expands CEERAM Food Safety Range to Global Market
7. Life Technologies Announces Filing of Definitive Proxy Statement
8. Novel study using new technologies outlines importance of California condor social groups
9. DryLet Technologies Announces Website Launch and New Logo Design for Patented MB Bioremediation
10. BioSpecifics Technologies Corp. Announces Partnership between Auxilium and Swedish Orphan Biovitrum AB for XIAPEX in Eurasia and Africa
11. Cell Therapy - Technologies, Markets and Companies - Updated 2013 with New Companies and Profiles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)...  OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS ... today announced a collaboration with University of California, ... test ImmunoPulse™ IL-12 as an immunotherapy in dogs ... the canine study are to advance the understanding ... and validate key clinical biomarkers. ...
(Date:6/1/2015)... Calif. , June 1, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... a Phase 2 clinical trial of AST-VAC1 in ... leukemia (AML). AST-VAC1 is the Company,s autologous (using ... cancer vaccine. AML is the most common form ...
(Date:5/31/2015)... BARCELONA, Spain , June 1, 2015 /PRNewswire/ ... company dedicated to rare diseases, has selected Veeva ... across sales, marketing, and medical. A complete solution, ... data, multichannel interactions, and compliant content to provide ... and effective commercial execution.      (Logo: ...
(Date:5/31/2015)... Grow Med University (GMU) is a free, ... at their own pace and dip into the rich ... both scientific and other informative articles, to hone their ... harvest yet! , The medical marijuana industry is ... in the U.S. and a slew of other businesses ...
Breaking Biology Technology:OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma 2OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma 3OncoSec Medical and UC Davis School of Veterinary Medicine Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma 4Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 2Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 3Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 4Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 5Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 6Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 7Sobi Establishes Global Commercial Operations in the Cloud with Best-in-Class Veeva Commercial Cloud 2Sobi Establishes Global Commercial Operations in the Cloud with Best-in-Class Veeva Commercial Cloud 3Grow Med University: a Brand New Online Hydroponics Course 2
... ATLANTA, Sept. 24 GeoVax Labs, Inc. ... company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), ... in the recently completed Phase 3 trial in Thailand of ... for Infectious Diseases. The completed study represents the first HIV/AIDS ...
... NEW YORK, Sept. 24 Reportlinker.com announces that a ... , Stem Cell Therapeutics Markets ... Political and business events presage change for stem cell ... lift federal funding restrictions on stem-cell research. The U.S. Congress has ...
... , , , ... CALP ), a leading provider of tools and services ... of XenoLight Rediject reagents at the World Molecular Imaging ... in an expanding range of XenoLight reagents for Caliper,s IVIS optical ...
Cached Biology Technology:Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy 2Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy 3Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy 4Reportlinker Adds Stem Cell Therapeutics Markets Report 2Reportlinker Adds Stem Cell Therapeutics Markets Report 3Reportlinker Adds Stem Cell Therapeutics Markets Report 4Reportlinker Adds Stem Cell Therapeutics Markets Report 5Reportlinker Adds Stem Cell Therapeutics Markets Report 6Reportlinker Adds Stem Cell Therapeutics Markets Report 7Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 2Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 3
(Date:5/22/2015)... -- According to a new market research ... Emotion, Forensic), by Software (Middleware, Databases), by Hardware (Cameras, Integrated ... Home) - Global Forecast to 2020", published by MarketsandMarkets, ... 2015 to $6.19 Billion by 2020, at a CAGR ... Tables and   43 Figures spread through 140 Pages ...
(Date:5/21/2015)... The Sync Project™ , a global collaboration harnessing ... a collaborative partnership with Berklee,s Institute for Creative ... on original research, joint course development and an internship ... Sync Project and BerkleeICE are exploring the launch of ... academic year.  The course will focus ...
(Date:5/20/2015)... Conn. , May 20, 2015 NXT-ID, ... announces that its wholly owned subsidiary, 3D-ID LLC, a ... under Team Battelle for the biometrics technology portion of ... Suite Contract from the Department of the Army. ... recognition products developed for government, law enforcement and security ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... Louisiana, US - Alligators display the same loyalty to ... in Molecular Ecology . The ten-year-study by scientists from ... of females chose to remain with their partner, often for ... Ruth Elsey, Tracey Tuberville and Stacey Lance, spent a decade ...
... in Spanish . , Individuals who follow ... grains and fish- appear less likely to develop depression, according ... the October issue of Archives of General Psychiatry . ... to be lower in Mediterranean than Northern European countries, according ...
... , This release is available in German . ... selectively transcribe parts of the DNA that makes up its genome ... proteins synthesized by a cell in turn determines its structure and ... crucial that the appropriate stretches of DNA are transcribed in each ...
Cached Biology News:Loyal alligators display the mating habits of birds 2Mediterranean diet associated with reduced risk of depression 2How RNA polymerase II gets the go-ahead for gene transcription 2How RNA polymerase II gets the go-ahead for gene transcription 3
WTAP Antibody...
Mouse monoclonal to Factor V Heavy Chain Immunogen: Purified human Factor V. Specificity: This antibody reacts with the activation C peptide (mw ~150,000) in the heavy chain of thrombin-cleave...
...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Biology Products: